Current status of cytokine-induced killer cells and combination regimens in breast cancer
Breast cancer remains a significant health challenge worldwide, with substantial efforts aimed at understanding its pathogenesis, biological characteristics, and clinical triggers. Recently, immunotherapy such as the cytokine-induced killer cells combined with other drug therapies has offered new ho...
Saved in:
Main Authors: | Yuancong Jiang, Jie Qiu, Nanwei Ye, Yingchun Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1476644/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01) -
Currents status of radiotracers for breast cancer imaging in PET
by: Chloé Jean, et al.
Published: (2025-03-01) -
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
by: Basingab FS, et al.
Published: (2025-01-01) -
Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
by: Biling Gan, et al.
Published: (2025-02-01) -
Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
by: Xue Wang, et al.
Published: (2025-01-01)